# Ixaka Limited (09427131)

> Why UK company 09427131 went into administration, from the administrators' statement filed at Companies House, by companydig. Interactive version: https://companydig.co.uk/company/09427131

- **Status:** Administration ended
- **Administration began:** 2023-08-02
- **Administrators:** Mark Guy Boughey, Michael Ian Field
- **Administrators' firm:** Mazars
- **Formerly:** Rexgenero Limited
- **Incorporated:** 2015-02-06
- **Location:** Bristol
- **Industry:** 86220 Specialists medical practice activities

## Why it went into administration

- Funding withdrawn / unable to refinance
- Regulatory change or action
- Loss of key people

## From the administrators' statement

The Company was formed in February 2015 as Rexgenero Limited. In January 2021 it was renamed to Ixaka Limited.

At the date of Administration the Company had four directors and four employees who operated remotely, and had the use of rented premises in central London.

The Company is a biotech business with the underline objective to cure disease through cell and gene therapy. The Company raised/managed funding for the group and carried out ‘head office’ functions, with the clinical trials being executed through its subsidiaries in Spain and France with the intention of selling the research data and trials information to the pharmaceutical industry at a point in the future.

Statement of proposals: https://find-and-update.company-information.service.gov.uk/company/09427131/filing-history/MzM5MjU1Nzc5MmFkaXF6a2N4/document?format=pdf&download=0
Companies House register: https://find-and-update.company-information.service.gov.uk/company/09427131

Contains public sector information from Companies House, licensed under the Open Government Licence v3.0.